Denali Therapeutics Inc. (DNLI)
NASDAQ: DNLI
· Real-Time Price · USD
14.79
0.33 (2.28%)
At close: Aug 15, 2025, 1:20 PM
Denali Therapeutics Revenue
Denali Therapeutics reported an annual revenue of $0, reflecting a -100% growth. For the quarter ending June 30, 2025, Denali Therapeutics generated $0 in revenue.
Revenue (ttm)
0
Revenue Growth
-100%
Price / Sales Ratio
0
Revenue / Employee
0
Employees
443
Market Cap
2.16B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|